Outpatient Care - Europe

Europe

The revenue in the Outpatient Care market in Europe is estimated to reach €175.60bn by 2024.
It is expected to experience an annual growth rate (CAGR 2024-2029) of 6.99%, leading to a market volume of €246.20bn by 2029.
When compared globally, United States is projected to generate the highest revenue in the Outpatient Care market, with an estimated amount of €690.60bn in 2024.
Germany's Outpatient Care market is experiencing a surge in telemedicine services, providing convenient and accessible healthcare options for patients across the country.

Key regions: United Kingdom, Japan, China, Brazil, Canada

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Outpatient Care market in Europe has experienced significant growth in recent years due to various factors that have influenced the healthcare industry.

Customer preferences: Patients in Europe are increasingly seeking more convenient and accessible healthcare options, which has led to a rise in demand for outpatient care services. This is particularly true for individuals with chronic conditions who require frequent medical attention but do not necessarily need to be hospitalized. Additionally, the aging population in Europe has also contributed to the growth of the outpatient care market as elderly patients prefer to receive medical care in a more comfortable and familiar environment.

Trends in the market: One of the major trends in the outpatient care market in Europe is the increasing adoption of telemedicine services. Telemedicine allows patients to receive medical care remotely, which is particularly beneficial for those living in rural areas or with mobility issues. This trend has been accelerated by the COVID-19 pandemic and is expected to continue in the future. Another trend in the market is the growing popularity of outpatient surgery, which is less invasive and requires less recovery time compared to traditional surgery. This has led to an increase in the number of outpatient surgery centers in Europe.

Local special circumstances: In countries like Germany, the outpatient care market is dominated by private practices, while in the United Kingdom, the National Health Service (NHS) provides most outpatient care services. In countries with a strong public healthcare system, such as France and Sweden, outpatient care services are often covered by the government, which has led to increased accessibility for patients.

Underlying macroeconomic factors: The growth of the outpatient care market in Europe can be attributed to various macroeconomic factors, including rising healthcare costs, an aging population, and advancements in medical technology. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, has led to a higher demand for outpatient care services. As a result, healthcare providers are expanding their outpatient care offerings to meet the needs of patients and remain competitive in the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.